Evidence map›Paper›PMID 38130595›Full record

ArticleOpen forum infectious diseases2023

Association of Chronic Medical Conditions With Severe Outcomes Among Nonpregnant Adults 18-49 Years Old Hospitalized With Influenza, FluSurv-NET, 2011-2019.

Efemona A Famati, Dawud Ujamaa, Alissa O'Halloran, Pam Daily Kirley, Shua J Chai, Isaac Armistead, Nisha B Alden, Kimberly Yousey-Hindes, Kyle P Openo, Patricia A Ryan and 19 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 14 institutions in 2 countries.

Efemona A FamatiInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Dawud UjamaaInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Alissa O'HalloranInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Pam Daily KirleyCalifornia Emerging Infections Program, Oakland, California, USA.
Shua J ChaiCalifornia Emerging Infections Program, Oakland, California, USA.
Isaac ArmisteadColorado Department of Public Health and Environment, Denver, Colorado, USA.
Nisha B AldenColorado Department of Public Health and Environment, Denver, Colorado, USA.
Kimberly Yousey-HindesEmerging Infections Program, Yale University School of Public Health, New Haven, Connecticut, USA.
Kyle P OpenoGeorgia Emerging Infections Program, Atlanta, Georgia, USA.
Patricia A RyanMaryland Department of Health, Baltimore, Maryland, USA.
Maya L MonroeMaryland Department of Health, Baltimore, Maryland, USA.
Anna FalkowskiMichigan Department of Health and Human Services, Lansing, Michigan, USA.
Sue KimMichigan Department of Health and Human Services, Lansing, Michigan, USA.
Ruth LynfieldMinnesota Department of Health, St.Paul, Minnesota, USA.
Melissa McMahonMinnesota Department of Health, St.Paul, Minnesota, USA.
Kathy M AngelesNew Mexico Emerging Infections Program, Albuquerque, New Mexico, USA.
Sarah A KhanlianNew Mexico Emerging Infections Program, Albuquerque, New Mexico, USA.
Nancy L SpinaNewYork State Department of Health, Albany, New York, USA.
Nancy M BennettUniversity of Rochester School of Medicine and Dentistry, Rochester, NewYork, USA.
Maria A GaitánUniversity of Rochester School of Medicine and Dentistry, Rochester, NewYork, USA.
Eli ShiltzOhio Department of Health, Columbus, Ohio, USA.
Krista LungOhio Department of Health, Columbus, Ohio, USA.
Ann ThomasOregon Health Authority, Portland, Oregon, USA.
H Keipp TalbotVanderbilt University School of Medicine, Nashville, Tennessee, USA.
William SchaffnerVanderbilt University School of Medicine, Nashville, Tennessee, USA.
Andrea GeorgeSalt Lake County Health Department, Salt Lake City, Utah, USA.
Holly StatenSalt Lake County Health Department, Salt Lake City, Utah, USA.
Catherine H BozioInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Shikha GargInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-9345-6669
Centers for Disease Control and Prevention · USColorado Department of Public Health and Environment · USLake County · USMaryland Department of Health · USMichigan Department of Health and Human Services · USMinnesota Department of Health · USOhio Department of Health · USUniversity of Rochester · USVanderbilt University · USEmory University · USNew Mexico Department of Health · USNew York State Department of Health · USOregon Health Authority · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Older age and chronic conditions are associated with severe influenza outcomes; however, data are only comprehensively available for adults ≥65 years old. Using data from the Influenza Hospitalization Surveillance Network (FluSurv-NET), we identified characteristics associated with severe outcomes in adults 18-49 years old hospitalized with influenza. Methods: We included FluSurv-NET data from nonpregnant adults 18-49 years old hospitalized with laboratory-confirmed influenza during the 2011-2012 through 2018-2019 seasons. We used bivariate and multivariable logistic regression to determine associations between select characteristics and severe outcomes including intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), and in-hospital death. Results: A total of 16 140 patients aged 18-49 years and hospitalized with influenza were included in the analysis; the median age was 39 years, and 26% received current-season influenza vaccine before hospitalization. Obesity, asthma, and diabetes mellitus were the most common chronic conditions. Conditions associated with a significantly increased risk of severe outcomes included age group 30-39 or 40-49 years (IMV, age group 30-39 years: adjusted odds ratio [aOR], 1.25; IMV, age group 40-49 years: aOR, 1.36; death, age group 30-39 years: aOR, 1.28; death, age group 40-49 years: aOR, 1.69), being unvaccinated (ICU: aOR, 1.18; IMV: aOR, 1.25; death: aOR, 1.48), and having chronic conditions including extreme obesity and chronic lung, cardiovascular, metabolic, neurologic, or liver diseases (ICU: range aOR, 1.22-1.56; IMV: range aOR, 1.17-1.54; death: range aOR, 1.43-2.36). Conclusions: To reduce the morbidity and mortality associated with influenza among adults aged 18-49 years, health care providers should strongly encourage receipt of annual influenza vaccine and lifestyle/behavioral modifications, particularly among those with chronic medical conditions.

Indexed as

adultschronic conditionshospitalizationsinfluenzasevere

Identifiers

PMID38130595
PMCPMC10733180
OpenAlexW4389120796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.